Miriam E. Tucker
![1]()
News
Real-world data show SGLT2 inhibitors for diabetes triple DKA risk
July 29, 2020
The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.
News
Even mild obesity raises severe COVID-19 risks
July 21, 2020
People with BMI of 30 kg/m2 or higher are at increased risk for severe illness, while BMI of 35 or greater dramatically increases the risk for death.
News
Guidance addresses elders with diabetes during COVID-19
July 16, 2020
Two geriatricians from the Joslin Diabetes Center offer advice for navigating the challenges associated with helping these vulnerable adults during the COVID-19 pandemic.
News
Hyperglycemia predicts COVID-19 death even without diabetes
July 13, 2020
This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.
News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
June 22, 2020
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.
News
Half of type 1 diabetes patients with COVID-19 manage at home
June 12, 2020
Despite high rates of hyperglycemia and DKA, only about half of patients with type 1 diabetes and COVID-19 required hospitalization, according to data from the T1D Exchange; mortality was low.
News
10% with diabetes hospitalized for COVID-19 die within a week
June 1, 2020
“Even in diabetes, each increase in BMI is associated with an increase in the risk of intubation and/or death in the 7 days following admission for COVID-19.”
News
‘The story unfolding is worrisome’ for diabetes and COVID-19
May 28, 2020
Diabetes Care has published a host of new articles on diabetes and COVID-19 infection, as NIDDK researchers also acknowledge risks to other organ systems from the SARS-CoV-2 virus.
News
Glucose control linked to COVID-19 outcomes in largest-yet study
May 15, 2020
Wuhan researchers found preexisting type 2 diabetes worsened prognosis of COVID-19; but those whose glucose stayed “in-range” had better outcomes.
News
COVID-19 triggers new bariatric/metabolic surgery guidance
May 15, 2020
Once pandemic restrictions are lifted, comorbidities should factor into which eligible patients should be the first to receive bariatric surgery.
